S1PR2 and cholestasis: Furthermore, we revealed the critical regulatory role of the GCDCA-S1PR2 signaling axis in cholestasis-associated hepatocarcinogenesis, providing novel mechanistic insights and identifying potential therapeutic targets for HCC treatment.